No significant strengths identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| MHLAMaiden Holdings, Ltd. 6.625 NT 2046 | 1.15B | 13.33 | -6.63 | -36.75% | -5.08% | -5.62% | 5.64 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.57B | 2.05B | 2.14B | 2.16B | 576.13M | 184.12M | 98.72M | 58.13M | 89.23M | 56.44M |
| Revenue Growth % | 0.08% | -0.2% | 0.04% | 0.01% | -0.73% | -0.68% | -0.46% | -0.41% | 0.54% | -0.37% |
| Medical Costs & Claims | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 2.57B | 2.05B | 2.14B | 2.16B | 576.13M | 184.12M | 98.72M | 58.13M | 89.23M | 56.44M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 0.08% | -0.2% | 0.04% | 0.01% | -0.73% | -0.68% | -0.46% | -0.41% | 0.54% | -0.37% |
| Operating Expenses | 2.42B | 1.94B | 2.27B | 2.6B | 667.09M | 39.12M | 36.02M | 30.95M | 30.8M | 35.35M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | -147.63M | 20.3M | 5.45M | 4.9M | 5.91M | 6.24M | 3.45M | 49.32M | 2.75M | 0 |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 147.63M | 96.58M | -113.42M | -429.49M | -93.67M | 145M | 62.7M | 27.18M | 58.44M | 21.09M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -0.06% | -0.35% | -2.17% | -2.79% | 0.78% | 2.55% | -0.57% | -0.57% | 1.15% | -0.64% |
| EBITDA | 0 | 116.88M | -107.97M | -424.59M | -87.76M | 151.25M | 66.15M | 76.5M | 61.18M | 21.09M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 19.32M | 0 | 0 | 0 | 19.27M |
| Non-Operating Income | -2.51B | -2B | -2.09B | -2.11B | -528.92M | -145M | -62.7M | -27.18M | -58.44M | 201.74M |
| Pretax Income | 126.32M | 79.47M | -154.41M | -449.85M | -110.27M | 41.66M | 26.66M | -60.6M | -38.37M | -199.91M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 2.04M | 413K | -6.76M | 441K | -911K | -104K | 15K | -557K | 196K | 1.05M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 100.09M | 46.14M | -176.98M | -476.16M | -109.36M | 41.76M | 26.64M | -60.04M | -38.57M | -200.97M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 0.3% | -0.54% | -4.84% | -1.69% | 0.77% | 1.38% | -0.36% | -3.25% | 0.36% | -4.21% |
| EPS (Diluted) | 1.17 | 0.59 | -2.07 | -5.73 | -1.32 | 0.93 | 1.35 | 0.63 | -0.38 | -2.01 |
| EPS Growth % | 0.13% | -0.5% | -4.51% | -1.77% | 0.77% | 1.7% | 0.45% | -0.53% | -1.6% | -4.29% |
| EPS (Basic) | 1.31 | 0.58 | -2.07 | -5.74 | -1.32 | 0.93 | 1.35 | 0.63 | -0.38 | -2.01 |
| Diluted Shares Outstanding | 85.64M | 78.69M | 85.68M | 83.05M | 83.06M | 84.33M | 86.07M | 87.11M | 101.38M | 99.9M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 5.64B | 6.25B | 6.64B | 5.29B | 3.57B | 2.95B | 2.32B | 1.85B | 1.52B | 1.32B |
| Asset Growth % | 0.09% | 0.11% | 0.06% | -0.2% | -0.33% | -0.17% | -0.21% | -0.2% | -0.18% | -0.13% |
| Total Investment Assets | 186.48M | 74.28M | 112.13M | 156.49M | 197.66M | 106.9M | 291.21M | 229.3M | 263.74M | 0 |
| Long-Term Investments | 186.48M | 13.06M | 6.6M | 23.72M | 31.75M | 106.9M | 225.47M | 228.91M | 263.74M | 0 |
| Short-Term Investments | -242.86M | 61.22M | 105.53M | 132.78M | 165.91M | 0 | 65.74M | 386K | 0 | 0 |
| Total Current Assets | 742.11M | 757.37M | 356.2M | 558.9M | 1.61B | 1.5B | 1.36B | 1.06B | 35.41M | 55.54M |
| Cash & Equivalents | 332.5M | 149.53M | 149.38M | 330.99M | 107.28M | 74.04M | 66.09M | 46.62M | 35.41M | 34.73M |
| Receivables | 0 | 0 | 1000K | 0 | 1000K | 1000K | 1000K | 1000K | 0 | 1000K |
| Other Current Assets | 742.11M | 757.37M | 0 | 558.9M | 1.61B | 1.5B | 1.36B | 1.06B | 0 | 0 |
| Goodwill & Intangibles | 479.47M | 502.32M | 380.2M | 388.44M | 77.36M | 51.9M | 36.7M | 24.98M | 17.57M | 8.1M |
| Goodwill | 58.94M | 57.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 420.53M | 445.13M | 380.2M | 388.44M | 77.36M | 51.9M | 36.7M | 24.98M | 17.57M | 8.1M |
| PP&E (Net) | 0 | 0 | 0 | 0 | 2.34M | 1.64M | 473K | 300K | 228K | 0 |
| Other Assets | 4.23B | 4.98B | 5.9B | 4.32B | 1.41B | 1.32B | 1.25B | 478.08M | 171.86M | 1.25B |
| Total Liabilities | 4.29B | 4.89B | 5.41B | 4.73B | 3.06B | 2.42B | 1.94B | 1.56B | 1.27B | 1.27B |
| Total Debt | 360M | 351.41M | 254.48M | 254.69M | 254.91M | 255.13M | 255.35M | 255.87M | 254.6M | 254.76M |
| Net Debt | 27.5M | 201.87M | 105.11M | -76.3M | 147.63M | 119.3M | 189.26M | 209.25M | 219.19M | -34.73M |
| Long-Term Debt | 360M | 351.41M | 254.48M | 254.69M | 254.91M | 255.13M | 255.35M | 255.57M | 254.6M | 254.76M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 201K | 0 |
| Total Current Liabilities | 2.65B | 3.06B | 2.48B | 3.12B | 30.1M | 51.36M | 1.53B | 1.24B | 24.03M | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47.71M | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.51B | -167.74M | -90.07M | -66.18M | 0 | 0 | 1.49B | 1.15B | -201K | 0 |
| Deferred Taxes | -1000K | 0 | 0 | 0 | 1000K | 1000K | 1000K | 0 | 0 | 0 |
| Other Liabilities | 3.85B | 4.54B | 5.16B | 4.48B | 0 | 53M | 44.54M | 1.31B | 991.14M | 1.02B |
| Total Equity | 1.35B | 1.36B | 1.23B | 554.92M | 507.72M | 527.82M | 384.26M | 284.58M | 249.16M | 45.19M |
| Equity Growth % | 0.09% | 0.01% | -0.09% | -0.55% | -0.09% | 0.04% | -0.27% | -0.26% | -0.12% | -0.82% |
| Shareholders Equity | 1.35B | 1.36B | 1.23B | 554.27M | 507.72M | 527.82M | 384.26M | 284.58M | 249.16M | 45.19M |
| Minority Interest | 1.28M | 355K | 452K | 641K | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 316.18M | 285.66M | 35.47M | -563.89M | -695.79M | -615.84M | -498.3M | -442.86M | -486.94M | -687.91M |
| Common Stock | 747K | 873K | 877K | 879K | 882K | 898K | 923K | 1.49M | 1.5M | 1.5M |
| Accumulated OCI | -23.77M | 15M | 13.35M | -65.62M | 17.84M | 23.86M | -12.21M | -41.23M | -31.47M | -32.73M |
| Return on Equity (ROE) | 0.08% | 0.03% | -0.14% | -0.53% | -0.21% | 0.08% | 0.06% | -0.18% | -0.14% | -1.37% |
| Return on Assets (ROA) | 0.02% | 0.01% | -0.03% | -0.08% | -0.02% | 0.01% | 0.01% | -0.03% | -0.02% | -0.14% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.27x | 0.26x | 0.21x | 0.46x | 0.50x | 0.48x | 0.66x | 0.90x | 1.02x | 5.64x |
| Book Value per Share | 15.75 | 17.30 | 14.39 | 6.68 | 6.11 | 6.26 | 4.46 | 3.27 | 2.46 | 0.45 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 634.3M | 470.13M | 458.57M | 182.29M | -1.14B | -541.77M | -394.43M | -195.93M | -59.78M | -67.45M |
| Operating CF Growth % | -0.03% | -0.26% | -0.02% | -0.6% | -7.27% | 0.53% | 0.27% | 0.5% | 0.69% | -0.13% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 124.42M | 48.97M | -147.82M | -450.53M | -109.36M | 41.76M | 25.62M | -60.35M | -38.57M | -200.97M |
| Depreciation & Amortization | 9.72M | 20.3M | 5.45M | 4.9M | 5.91M | 6.24M | 3.45M | -2.85M | 2.75M | 0 |
| Stock-Based Compensation | 2.94M | 3.41M | 2.94M | 1.28M | 1.91M | 2.44M | 4.77M | 2.74M | 1.73M | -5.26M |
| Deferred Taxes | 0 | 0 | 0 | 0 | -13.73M | -14.93M | -11.68M | 112K | -7.21M | 0 |
| Other Non-Cash Items | 519.59M | 21.39M | 50.7M | -85.1M | -19.08M | -81.43M | -55.7M | -33.03M | -30.06M | -30.99M |
| Working Capital Changes | 354.85M | 420.08M | 561.14M | 722.82M | -1.01B | -495.87M | -360.9M | -102.55M | 11.6M | 169.77M |
| Cash from Investing | -750.68M | -439.2M | -359.86M | 32.9M | 913.18M | 596.04M | 464.06M | 188.79M | 58.51M | 77.74M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | -421K | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 255.92M | 0 | 0 | 421K | 2.73M | 0 | 0 |
| Purchase of Investments | -1.46B | -1.37B | -838.89M | -1.02B | -2.02B | -532.07M | -367.29M | -191.87M | -247.84M | -37.77M |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 1000K |
| Other Investing | 7.43M | 138.24M | -51.82M | 102.79M | -2.87M | -608K | 396K | -88K | 306.35M | 14.57M |
| Cash from Financing | 99.75M | -76.78M | -60.42M | -68.03M | -18K | -30.13M | -138.9M | -10.98M | -3.02M | -3.73M |
| Dividends Paid | -62.54M | -76.88M | -80.79M | -67.19M | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -654K | -470K | -25.65M | -873K | -18K | -1K | -2.48M | -1.01M | -2.92M | -3.73M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 0 | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | -95K | 0 |
| Other Financing | 162.95M | 1.79M | 146.02M | 31K | 0 | -30.13M | -136.42M | -9.97M | 0 | 0 |
| Net Change in Cash | 224.38M | 59.89M | -160K | 181.61M | -223.71M | 28.55M | -69.74M | -19.46M | -3.95M | 5.41M |
| Exchange Rate Effect | -1000K | 1000K | 1000K | -1000K | -382K | 1000K | -470K | -1000K | 335K | -1000K |
| Cash at Beginning | 108.12M | 89.64M | 149.53M | 149.38M | 330.99M | 107.28M | 135.83M | 66.09M | 46.62M | 42.68M |
| Cash at End | 332.5M | 149.53M | 149.38M | 330.99M | 107.28M | 135.83M | 66.09M | 46.62M | 42.68M | 48.08M |
| Free Cash Flow | 634.3M | 470.13M | 458.57M | 182.29M | -1.14B | -541.77M | -394.85M | -195.93M | -59.78M | -67.45M |
| FCF Growth % | -0.03% | -0.26% | -0.02% | -0.6% | -7.27% | 0.53% | 0.27% | 0.5% | 0.69% | -0.13% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | 7.41 | 5.97 | 5.35 | 2.19 | -13.76 | -6.42 | -4.59 | -2.25 | -0.59 | -0.68 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 93.96% | 94.64% | 106% | 119.89% | 115.79% | 21.25% | 36.49% | 53.24% | 34.51% | 62.63% |
| Medical Cost Ratio | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Return on Equity (ROE) | 7.73% | 3.4% | -13.65% | -53.28% | -20.58% | 8.07% | 5.84% | -17.95% | -14.45% | -136.55% |
| Return on Assets (ROA) | 1.85% | 0.78% | -2.74% | -7.98% | -2.47% | 1.28% | 1.01% | -2.88% | -2.29% | -14.18% |
| Equity / Assets | 23.91% | 21.77% | 18.55% | 10.49% | 14.23% | 17.9% | 16.54% | 15.41% | 16.4% | 3.43% |
| Book Value / Share | 15.75 | 17.3 | 14.39 | 6.68 | 6.11 | 6.26 | 4.46 | 3.27 | 2.46 | 0.45 |
| Debt / Equity | 0.27x | 0.26x | 0.21x | 0.46x | 0.50x | 0.48x | 0.66x | 0.90x | 1.02x | 5.64x |
| Revenue Growth | 8.06% | -20.26% | 4.24% | 1.22% | -73.39% | -68.04% | -46.38% | -41.11% | 53.5% | -36.75% |
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|---|---|
| Diversified Reinsurance | 795.34M | 762.06M | 854.03M | 744.88M | 724.12M | 823.37M | 112.49M |
| Diversified Reinsurance Growth | - | -4.18% | 12.07% | -12.78% | -2.79% | 13.70% | -86.34% |
| AmTrust Reinsurance | - | - | 1.38B | 1.68B | 1.84B | 1.91B | - |
| AmTrust Reinsurance Growth | - | - | - | 22.19% | 9.47% | 3.58% | - |
| AmTrust Quota Share Reinsurance | 727.78M | 988.9M | - | - | - | - | - |
| AmTrust Quota Share Reinsurance Growth | - | 35.88% | - | - | - | - | - |
| NGHC Quota Share | - | 249.92M | - | - | - | - | - |
| NGHC Quota Share Growth | - | - | - | - | - | - | - |
| ACAC Quota Share | 280.66M | - | - | - | - | - | - |
| ACAC Quota Share Growth | - | - | - | - | - | - | - |
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) saw revenue decline by 36.8% over the past year.
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) reported a net loss of $211.1M for fiscal year 2024.
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) has a return on equity (ROE) of -136.5%. Negative ROE indicates the company is unprofitable.
Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) has a combined ratio of 0.0%. A ratio below 100% indicates underwriting profitability.